IRIS - Res&Arch Institutional Research Information System - Research & Archive

FANELLI, Carmine Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.757
EU - Europa 4.295
AS - Asia 4.048
SA - Sud America 660
Continente sconosciuto - Info sul continente non disponibili 326
AF - Africa 101
OC - Oceania 25
Totale 15.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.589
SG - Singapore 2.000
IT - Italia 601
IE - Irlanda 598
UA - Ucraina 588
CN - Cina 583
RU - Federazione Russa 576
SE - Svezia 527
BR - Brasile 521
HK - Hong Kong 417
DE - Germania 355
FR - Francia 332
VN - Vietnam 328
FI - Finlandia 224
BD - Bangladesh 161
GB - Regno Unito 147
KR - Corea 96
IN - India 94
ES - Italia 83
CA - Canada 75
TR - Turchia 72
PL - Polonia 53
AT - Austria 52
AR - Argentina 49
MX - Messico 49
JP - Giappone 44
IQ - Iraq 40
ZA - Sudafrica 40
NL - Olanda 37
UZ - Uzbekistan 32
PK - Pakistan 24
ID - Indonesia 23
AU - Australia 21
CH - Svizzera 21
CO - Colombia 20
SA - Arabia Saudita 20
CZ - Repubblica Ceca 17
EC - Ecuador 17
PH - Filippine 17
BE - Belgio 15
MA - Marocco 15
VE - Venezuela 15
GR - Grecia 13
JO - Giordania 12
PE - Perù 11
KE - Kenya 10
MY - Malesia 10
NP - Nepal 10
CL - Cile 9
CR - Costa Rica 9
LB - Libano 9
AZ - Azerbaigian 8
LT - Lituania 8
RO - Romania 8
TT - Trinidad e Tobago 8
JM - Giamaica 7
KZ - Kazakistan 7
PY - Paraguay 7
TN - Tunisia 7
BO - Bolivia 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
EG - Egitto 5
IL - Israele 5
OM - Oman 5
AL - Albania 4
DZ - Algeria 4
PS - Palestinian Territory 4
RS - Serbia 4
SV - El Salvador 4
TH - Thailandia 4
BH - Bahrain 3
CI - Costa d'Avorio 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
GH - Ghana 2
HU - Ungheria 2
IM - Isola di Man 2
KG - Kirghizistan 2
KH - Cambogia 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
TG - Togo 2
AF - Afghanistan, Repubblica islamica di 1
Totale 14.869
Salva come PNG Salva come JPEG
Città #
Singapore 1.413
Chandler 684
San Jose 611
Dublin 598
Hong Kong 410
San Mateo 346
Ashburn 339
Boardman 278
Jacksonville 271
Santa Clara 227
Altamura 192
Medford 172
Princeton 169
Moscow 164
Lauterbourg 155
Beijing 151
Wilmington 144
Lawrence 129
Perugia 120
Munich 117
New York 117
Los Angeles 105
Seoul 93
Ann Arbor 88
Des Moines 88
Dong Ket 85
Andover 78
Helsinki 76
Ho Chi Minh City 69
Saint Petersburg 53
Frankfurt am Main 51
The Dalles 51
São Paulo 50
Valencia 50
Hanoi 46
Piscataway 41
Rome 41
Brooklyn 37
Tokyo 37
Falls Church 35
Chicago 32
Warsaw 31
Orem 30
Izmir 28
Woodbridge 27
Montreal 25
Norwalk 25
Nuremberg 25
Dallas 24
Stockholm 24
Tashkent 23
Vienna 23
San Francisco 21
Amsterdam 20
Milan 20
Toronto 20
Turku 20
Buffalo 19
Denver 17
Fremont 17
London 17
Baghdad 16
Shanghai 16
Amelia 15
Ankara 15
Atlanta 15
Da Nang 15
Istanbul 15
Mexico City 15
San Paolo di Civitate 15
Falkenstein 14
Redmond 14
Rio de Janeiro 14
Brussels 13
Houston 13
Amman 12
Haiphong 12
Johannesburg 12
Boston 11
Brno 11
Phoenix 11
Auburn Hills 10
Belo Horizonte 10
Chennai 10
Council Bluffs 10
Poplar 10
Roubaix 10
Brasília 9
Buenos Aires 9
Campinas 9
Charlotte 9
Curitiba 9
Foligno 9
Goiânia 9
Guayaquil 9
Mumbai 9
Porto Alegre 9
San José 9
Bolton 8
Lima 8
Totale 8.918
Salva come PNG Salva come JPEG
Nome #
Adrenaline vs glucagon in the primacy of glucose counterregulation 175
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 169
Different brain responses to hypoglycemia induced by equipotent doses of long-acting insulin analog detemir and human regular insulin in humans 158
Hypoglycemia 154
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 151
Administration of neutral protamine Hagerdon insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. 150
Physical activity habits and well-being among 6-year-old children: The “improving umbrian kids’ healthy lifestyle”, an uncontrolled pilot study project 147
An intensive lifestyle intervention in children with attention-deficit/hyperactivity disorder 144
Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes 138
18. Insulin required for prandial ghrelin suppression in humans 137
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 135
Physical activity level and mediterranean diet adherence evaluation in older people - observational, uncontrolled, pilot study 134
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 128
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 128
A novel surrogate index for hepatic insulin resistance. 126
Administration of Neutral Protamine Hagedorn insulin at bedtime versus dinner in Type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control: a randomized, controlled trial. 125
Effects of an Intensive Lifestyle Intervention to Treat Overweight/Obese Children and Adolescents 123
Intensive lifestyle intervention is particularly advantageous in poorly controlled type 2 diabetes 121
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia 120
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 120
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 120
Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans 120
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 119
Cognitive function in hypoglycaemia 117
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 116
Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs 115
Ipoglicemia: implicazioni cliniche e impatto sulla salute 115
Adrenergic mechanisms do not contribute to glucose counterregulation during acute insulin-induced hypoglycaemia in normal man. 114
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 113
Uso dell’analogo ad azione rapida lispro con l’analogo ad azione ritardo glargine nel trattamento intensivo del T1DM 112
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. 112
IMPACT OF NOCTURNAL HYPOGLYCEMIA ON HYPOGLYCEMIC COGNITIVE DYSFUNCTION IN TYPE 1 DIABETES 111
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 110
Evaluation of maximum oxygen consumption in obese adolescents before and after a multidisciplinary lifestyle intervention 109
Insulin is required for prandial ghrelin suppression in humans 109
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 108
Counterregulatory hormone and symptom responses to insulin-induced hypoglycaemia in the postprandial state in humans 105
Are three months multidisciplinary lifestyle intervention enough to get benefits on blood pressure in overweight/obese adults ? 104
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting analogue at mealtime. A three month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. 103
Nocturnal blood glucose control in type I diabetes mellitus. 103
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 103
Effects of a supervised nordic walking program on obese adults with and without type 2 diabetes: The C.U.R.I.A.Mo. Centre experience 102
Early improvement of glucose tolerance after ileal transposition in a nonobese Type 2 diabetes rat model. 101
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules 101
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 101
Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs 100
The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity 99
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 99
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin 99
Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes 99
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 97
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 97
Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. 96
Body composition and common carotid artery remodeling in a healthy population 96
Hyperglycemia, Both Chronic and in Short-Term Peaks, Results in Rapid Increase of Expression of Monocyte Inducible Cyclooxygenase (COX-2) in Subjects with T2DM 95
Glucagon: the effects of its excess and deficiency on insulin action 94
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 94
Nutritional Management of Athletes with Type 1 Diabetes: A Narrative Review 93
Intensive replacement of basal insulin in patients with Type 1 diabetes mellitus given rapid-acting insulin analogue at meal-time: a three-month comparison between administration of NPH four times daily and glargine insulin at dinner or bedtime. 93
Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. 93
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 93
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 93
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 93
Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia 91
Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans. 91
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro 91
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. 89
Premeal Insulin Treatment During Basal-Bolus Regimen in Young Children With Type 1 Diabetes 89
Impact of BMI, Physical Activity, and Sitting Time Levels on Health-Related Outcomes in a Group of Overweight and Obese Adults with and without Type 2 Diabetes 89
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people. 88
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 87
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 86
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus. 85
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 85
Ipoglicemia: cause e prevenzione 84
Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. 84
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 84
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. 83
Circulatin ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 83
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 83
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 83
The impact of ideglira in treatment simplification in older adults with type 2 diabetes mellitus already on insulin therapy: The stop study 82
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 82
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 82
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 82
A multistep approach for the stratification of the risk of severe hypoglycemia in patients with type 2 diabetes 82
Is physical activity a necessary element during Italian coronavirus disease emergency? Yes or no debate 82
Counterregulatory responses in CSII 81
Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. 81
Obesity and carotid artery remodeling 81
Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus 79
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 79
"Strength gains in different age groups of overweight/obese adults: A pilot uncontrolled study" 77
Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage 76
Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus 76
Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population 75
Responses to hypoglycemia in diabetic autonomic neuropathy. 75
Insulin therapy and hypoglycemia: the size of the problem 74
Quando “i conti non tornano” (Caso clinico) G It Diabetol Metab 26:172-175 73
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. 73
Totale 10.296
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.253 0 233 30 83 34 20 20 407 16 32 137 241
2022/20232.310 184 465 31 191 170 287 5 95 788 3 67 24
2023/2024982 54 105 43 33 8 8 195 14 77 39 185 221
2024/20252.340 36 230 81 126 366 65 59 182 513 167 304 211
2025/20265.525 360 325 266 603 779 408 1.004 280 738 414 179 169
2026/2027332 193 139 0 0 0 0 0 0 0 0 0 0
Totale 15.212